Refine
Has Fulltext
- yes (22)
Is part of the Bibliography
- yes (22)
Year of publication
Document Type
- Journal article (22)
Language
- English (22)
Keywords
- ADHD (5)
- mice (3)
- prefrontal cortex (3)
- serotonin (3)
- SLC2A3 (2)
- attention-deficit/hyperactivity disorder (ADHD) (2)
- chronic stress (2)
- hippocampus (2)
- neurodevelopment (2)
- pro-inflammatory cytokines (2)
- psychiatric disorders (2)
- 3-dimensional MRI (1)
- 5-HT receptors (1)
- 5-HTT (1)
- 5-HTTLPR polymorphism (1)
- Adult (1)
- Aggression (1)
- Antisocial behavior (1)
- Association (1)
- C57BL/6 mice (1)
- CB1 receptor antagonists (1)
- COMT (1)
- Central nervous system (1)
- Conduct disorder (1)
- DRD4 (1)
- Deficit/hyperactivity disorder (1)
- Diagnostic approach (1)
- Dopamine (1)
- Fgf-signalling (1)
- GLUT3 (1)
- GWAS (1)
- Gene (1)
- Hypothalamus (1)
- Large multicenter ADHD (1)
- NMDA receptor subunits NR2A and NR2B (1)
- OXTR (1)
- Rating scale (1)
- SARS-CoV-2 (1)
- SSRI (1)
- Serotonin (1)
- Susceptibility loci (1)
- T-cadherin (1)
- Xenopus laevis oocytes (1)
- adulthood (1)
- aging (1)
- allostatic load (1)
- amino acid analysis (1)
- anhedonia (1)
- animal behavior (1)
- antioxidant nutrients (1)
- anxiety (1)
- anxiety-like behavior (1)
- association (1)
- attention (1)
- blood flow (1)
- cadherin-13 (CDH13) (1)
- celecoxib (1)
- cell membranes (1)
- childhood maltreatment (1)
- chronic social stress (1)
- citalopram (1)
- collagens (1)
- comparative genomics (1)
- copy number variation (1)
- crystal structure (1)
- dangerous world (1)
- depression (1)
- developmental plasticity (1)
- dicholine succinate (1)
- dorsal raphe (1)
- electroencephalogram (EEG) (1)
- elevated plus-maze (1)
- energy metabolism (1)
- environment interaction (1)
- environmental enrichment (1)
- events (1)
- false belief (1)
- fear conditioning (1)
- female aggression (1)
- forced swimming (1)
- genetic variants (1)
- glucose (1)
- glucose transporter (1)
- glycogen synthase kinase-3 β (GSK-3β) (1)
- hippocampal neurogenesis (1)
- hippocampal plasticity (1)
- hyperactivity (1)
- impulsivity (1)
- induced pluripotent stem cells (1)
- inducible cyclooxygenase-2 (COX-2) (1)
- inflammation (1)
- insulin receptor (1)
- insulin receptor (IR) (1)
- integrins (1)
- ischemic stroke (1)
- knockout mice (1)
- lactosylceramide alpha-2,3-sialyltransferase (ST3GAL5) (1)
- lerned helplessness (1)
- life history (1)
- life stress (1)
- linked polymorphic region (1)
- major depression (1)
- match-mismatch (1)
- maternal care (1)
- membrane potential (1)
- membrane proteins (1)
- metaanalysis (1)
- moderation (1)
- molecular neuroscience (1)
- mouse (1)
- mouse model (1)
- mouse-brain (1)
- myelination (1)
- neurodegeneration (1)
- oxidative stress (1)
- phosphorylated glycogen synthase kinase-3beta (pGSK-3beta) (1)
- platelet activation (1)
- platelet aggregation (1)
- platelets (1)
- polygenic risk score (1)
- polymorphism (1)
- post-traumatic stress disorder (1)
- predation stress (1)
- predictive adaptive response hypothesis (1)
- radial glia (1)
- rare mendelian disorders (1)
- rhesus macaques (1)
- s allele (1)
- serotonin transporter gene (1)
- sex differences (1)
- sialic acid (1)
- sialyltransferase (1)
- sleep EEG (1)
- stress resilience (1)
- substance abuse disorder (1)
- theory of mind (1)
- toll-like receptors (1)
- tryptophan hydroxylase-2 (Tph2) (1)
- venturesomeness (1)
- white-matter integrity (1)
Institute
- Lehrstuhl für Molekulare Psychiatrie (22) (remove)
Sodium-glucose transporters (SGLT) belong to the solute carrier 5 family, which is characterized by sodium dependent transport of sugars and other solutes. In contrast, the human SGLT3 (hSGLT3) isoform, encoded by SLC5A4, acts as a glucose sensor that does not transport sugar but induces membrane depolarization by Na\(^{+}\) currents upon ligand binding. Whole-exome sequencing (WES) of several extended pedigrees with high density of attention-deficit/hyperactivity disorder (ADHD) identified a triplet ATG deletion in SLC5A4 leading to a single amino acid loss (ΔM500) in the hSGLT3 protein imperfectly co-segregating with the clinical phenotype of ADHD. Since mutations in homologous domains of hSGLT1 and hSGLT2 were found to affect intestinal and renal function, respectively, we analyzed the functional properties of hSGLT3[wt] and [ΔM500] by voltage clamp and current clamp recordings from cRNA-injected Xenopus laevis oocytes.
The cation conductance of hSGLT3[wt] was activated by application of glucose or the specific agonist 1-desoxynojirimycin (DNJ) as revealed by inward currents in the voltage clamp configuration and cell depolarization in the current clamp mode. Almost no currents and changes in membrane potential were observed when glucose or DNJ were applied to hSGLT3[ΔM500]-injected oocytes, demonstrating a loss of function by this amino acid deletion in hSGLT3. To monitor membrane targeting of wt and mutant hSGLT3, fusion constructs with YFP were generated, heterologously expressed in Xenopus laevis oocytes and analyzed for membrane fluorescence by confocal microscopy. In comparison to hSGLT3[wt] the fluorescent signal of mutant [ΔM500] was reduced by 43% indicating that the mutant phenotype might mainly result from inaccurate membrane targeting. As revealed by homology modeling, residue M500 is located in TM11 suggesting that in addition to the core structure (TM1-TM10) of the transporter, the surrounding TMs are equally crucial for transport/sensor function.
In conclusion, our findings indicate that the deletion [ΔM500] in hSGLT3 inhibits membrane targeting and thus largely disrupts glucose-induced sodium conductance, which may, in interaction with other ADHD risk-related gene variants, influence the risk for ADHD in deletion carriers.
In most vertebrates, including zebrafish, the hypothalamic serotonergic cerebrospinal fluid-contacting (CSF-c) cells constitute a prominent population. In contrast to the hindbrain serotonergic neurons, little is known about the development and function of these cells. Here, we identify fibroblast growth factor (Fgf)3 as the main Fgf ligand controlling the ontogeny of serotonergic CSF-c cells. We show that fgf3 positively regulates the number of serotonergic CSF-c cells, as well as a subset of dopaminergic and neuroendocrine cells in the posterior hypothalamus via control of proliferation and cell survival. Further, expression of the ETS-domain transcription factor etv5b is downregulated after fgf3 impairment. Previous findings identified etv5b as critical for the proliferation of serotonergic progenitors in the hypothalamus, and therefore we now suggest that Fgf3 acts via etv5b during early development to ultimately control the number of mature serotonergic CSF-c cells. Moreover, our analysis of the developing hypothalamic transcriptome shows that the expression of fgf3 is upregulated upon fgf3 loss-of-function, suggesting activation of a self-compensatory mechanism. Together, these results highlight Fgf3 in a novel context as part of a signalling pathway of critical importance for hypothalamic development.